News • Pathogen Analyzer
Researchers develop cost-effective PCR test alternative
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
Bringing diagnostics to the patient: Point-of-Care-Testing (POCT) is all about examinations close to the patient – in the hospital ward, at the GP, in the ambulance or even in the patient's home. Keep reading for new developments and applications from rapid medical laboratory tests to mobile imaging solutions.
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
The Pluslife Mini Dock System is a Next-Generation POC molecular diagnostic tool that can be used in different application scenarios, which aims to help the decentralization of MDx in diagnosing facilities.
The coronavirus pandemic is a huge challenge for global public health and welfare. Decentralized, affordable POC MDx platforms would allow more effective control of SARS-CoV-2 and other infections.
The prototype device combines eRapid and SHERLOCK technologies into a single, postcard-sized system that can simultaneously detect the presence of both SARS-CoV-2 RNA and antibodies in a patient’s saliva.
The development of a simple blood test for glioblastomas could mean earlier diagnosis and more effective and personalised treatment options against the most common type of malignant brain cancer.
Researchers have developed a new Covid-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have Covid-19.
The speedy, high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing.
The European Society for Emergency Medicine (EUSEM) held their annual congress on October 27th to 31st, 2021 in the city of Lisbon, to promote education, training and research in European acute care.
Handheld, instrument-free test delivers lab-quality molecular results – 97.9% accuracy – in about 15 minutes, right at the point of care.
A new handheld device has been developed to painlessly identify skin cancers using millimeter-wave imaging. This could slash the rate of unnecessary biopsies.
Point-of-care testing (POCT) is a “win-win” scenario for patients and healthcare professionals in delivering care when and where it is needed, according to pathologist Adil Khan, MSc, PhD.
Ion-mobility spectrometry (IMS) offers opportunities for rapid diagnosis and clinical decision-making due to breath analysis. As a rapid separation tool, it has clinical value in the identification and analysis of proteins, peptides, lipids, and glycans. The tool is already used as an exhaled drug monitor for anaesthetised patients. It is flexible, portable and has use for point-of-care testing,…
Considerable advances in point-of-care testing (POCT) devices are emerging from lab-on-a-chip platforms, innovations in smartphone-based technology and wearable technology. Cloud-based deep learning systems herald a future revolution.
Fluxergy envisions that a fully articulated democratized testing health system has the potential to reduce the likelihood and the ultimate severity of pandemics like Covid-19. Our mission is to unlock the true potential of diagnostics to play a far greater and more important role in the early detection of diseases and ongoing monitoring of health status, where and when it matters most: at the…
Siemens Healthineers announced the company's Atellica VTLi Patient-Side Immunoassay Analyzer has obtained CE mark and is expected to be available later this spring. The Atellica VTLi analyzer provides lab standard, high-sensitivity cardiac troponin I (hs-cTnI) test results to clinicians in eight minutes using a patient's fingerstick blood sample. With this industry first technology, Siemens…
Now Available: The Fluxergy Analyzer System is a testing platform designed for sample-to-answer point-of-care testing, enabling clinicians to cost-effectively conduct molecular in vitro diagnostic tests. The analyzer system is designed to deliver test results within one hour. This device is solely intended to be used by healthcare professionals.
In vitro diagnostics company EKF Diagnostics announces the global launch of its Stat-Site WB handheld analyzer which delivers β-ketone and glucose measurements from whole blood in seconds. The portable, dual-purpose analyzer is designed for professional use in the management of diabetes patients. The device is used for the quantitative determination of β-ketones (Beta-Hydroxybutyrate or BHB)…
Due to the coronavirus, hospitals and medical staff developed new work practices involving, in acute settings, social distancing, rigid use of personal protective equipment (PPE), handwashing, and disinfection of equipment every day. Additionally, portable, highly-mobile and versatile equipment came to the fore in point-of-care (POC) – particularly when wards and operating theatres are spread…
This July, Fujifilm Sonosite launched Sonosite PX, its newest ultrasound system, in the midst of the Covid-19 pandemic. Diku Mandavia, M.D., Chief Medical Officer of Fujifilm Sonosite, sat down with sonographer and Sonosite’s Director of Marketing Development Jodi Miller to discuss how Sonosite’s newest ultrasound system can help frontline health care workers combat the pandemic and why…